Tag: Kite Car T therapy Yescarta

Kite Car T therapy Yescarta bags FDA approval for type of lymphatic cancer

Yescarta FDA approval : Kite Pharma has bagged the US FDA approval for its chimeric antigen receptor T cell (CAR T) therapy Yescarta (axicabtagene ciloleucel) ... Read More